Baylor Genetics

Overview

Baylor Genetics is a United States-based company founded in 1996, operating within the business services industry, specifically focusing on research and development. The company specializes in genetic testing and analysis, as evidenced by their published documentation. One notable case study highlights the use of Chromosomal Microarray Analysis (CMA) to identify compound heterozygous deletions in a newborn diagnosed with dual genetic conditions, including 22q11.2 deletion syndrome and a homozygous deletion of the TANGO2 gene. This case illustrates the effectiveness of CMA in detecting multiple copy number variations (CNVs) in a single patient, which can lead to early diagnosis and informed medical management. Baylor Genetics emphasizes the importance of precise genetic testing in understanding complex genetic disorders and improving patient outcomes. The company employs between 51 and 200 individuals and reported revenue of approximately $33.4 million, reflecting its position within the genetic research and diagnostics sector.

Industry